Juliet Thompson

Juliet joined the OrganOx board in January 2021 as a Non-Executive Director, appointed on behalf of the University of Oxford and the Technikos Parties, and Chair of the Audit Committee. Juliet has spent over 20 years actively involved in the life sciences sector working as an investment banker and strategic adviser to healthcare companies in Europe. She headed up the European healthcare team at Stifel (formerly Oriel) and prior to this was a founding partner of Code Securities, a healthcare investment banking boutique which was acquired by Nomura, later forming Nomura Code. Juliet sits on the boards of public companies Vectura plc and Novacyt S.A. and chairs the Audit Committee of both companies.